Skip to main content

Month: June 2020

Winnebago Industries’ Third Quarter Fiscal 2020 Financial Results Announcement to be Made on June 24, 2020

FOREST CITY, Iowa, June 10, 2020 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, plans to issue its earnings release for its third quarter Fiscal 2020 before the market opens on June 24, 2020. The Company will also host a conference call to discuss the financial results for the quarter on Wednesday, June 24, 2020, at 9 a.m. CDT. All interested parties are invited to listen live via the Company’s website, http://investor.wgo.net. The event will be archived and available for replay for the next 90 days. To access the replay, click on https://winnebago.gcs-web.com/event-calendar.About Winnebago IndustriesWinnebago Industries, Inc. is a leading U.S. manufacturer of outdoor lifestyle products under the Winnebago, Grand Design, Newmar and Chris-Craft brands, which are...

Continue reading

PSYC Expanding Their Global Reach To Showcase Psychedelic Industry Leaders and Pioneers

SAN DIEGO, CA, June 10, 2020 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that in an effort to provide its growing base of Psychedelic Spotlight newsletter subscribers with exclusive content surrounding the ongoing boom within the medicinal psychedelics space, the Company plans to launch a series of exclusive interviews with some of today’s industry-leading advocates, pioneers, and trail blazers.“Immersing ourselves within this industry and becoming a true ally for those who are currently advocating for a variety of psychedelic-related treatments is a very important objective of ours,” said Vanessa Luna Global Trac Solutions, Inc. CEO. “There are a multitude of individuals across the globe who are working incredibly hard to shed an important and valuable...

Continue reading

The Chefs’ Warehouse, Inc. to Participate at the Jefferies Consumer Conference

RIDGEFIELD, Conn., June 10, 2020 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF), a premier distributor of specialty food products in the United States, today announced that the Company will present at the virtual Jefferies Consumer Conference on Wednesday, June 24, 2020. The presentation will begin at 1:30 p.m. ET.Investors and interested parties may listen to a webcast of the presentation by visiting the Company’s investor relations website at http://investors.chefswarehouse.com/.About The Chefs’ WarehouseThe Chefs’ Warehouse, Inc. is a premier distributor of specialty food products in the United States and Canada focused on serving the specific needs of chefs who own and/or operate some of the nation’s leading menu-driven independent restaurants, fine dining establishments, country clubs, hotels, caterers,...

Continue reading

University of Kansas Medical Center to Deploy OMNIQ’s Artificial Intelligence – Cloud Based Access Control Parking and Security System

University will implement  the cloud-based Permitting, Enforcement and Revenue Citation System (PERCSTM), significantly improving campus safety and enabling virtual access control via permits, time enforced parking and citation revenue collectionSystem uses OMNIQ’s  AI-Machine Vision Vehicle Recognition technology to improve vehicle access, enhance Public Safety, increase Automation and enable Smart City projectsUniversity of Kansas Medical Center (KUMC) is a new customer for OMNIQSALT LAKE CITY, June 10, 2020 (GLOBE NEWSWIRE) — OMNIQ, Inc. (OTCQB:OMQS) (“OMNIQ”or “the Company”),  announces that it has received an order to for its new PERCSTM cloud-based permitting, citation, access control and parking collection system from the University of Kansas Medical Center. Based on OMNIQ’s AI-Machine Vision technology for License Plate and...

Continue reading

OrthoPediatrics Corp. Commences Initial U.S. Launch of ApiFix’s FDA-Approved Spinal Deformity Correction System

WARSAW, Ind., June 10, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the initial U.S. launch of the ApiFix Minimally Invasive Deformity Correction (“ApiFix”) system. Additionally, the Company anticipates approximately 20 leading clinical centers in the United States to enter data related to the use of the ApiFix system into a post-approval study registry hosted by the Pediatric Spine Study Group in order to continue monitoring the safety and probable benefit of the device for the treatment of progressive adolescent idiopathic scoliosis (“AIS”).The ApiFix technology is a posterior dynamic deformity correction system approved for use in AIS patients with Lenke type 1 and Lenke type...

Continue reading

Standard Uranium Ltd. Announces Further Upsize To Previously Announced Public Offering To C$4,000,000

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 10, 2020 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) is pleased to announce that it has entered into an amended letter agreement (the “Amended Agreement”) with Red Cloud Securities Inc. (“Red Cloud”) to act as lead agent on behalf of a syndicate of agents including Eight Capital (collectively, the “Agents”) in connection with the upsize of its previously announced public offering of units (the “Offered Securities”) for gross proceeds of C$3,000,000 (the “Initial Offering”).  The Company announced an upsize to the Initial Offering to C$3,500,000 on June 8, 2020 and now intends to upsize the Initial Offering to C$4,000,000 to accommodate investor demand...

Continue reading

Fluent Partners with Zendesk to Enhance Consumer Experience

NEW YORK, June 10, 2020 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading performance marketing company, today announced it has partnered with Zendesk, Inc. (NYSE: ZEN), a service-first customer relationship management (CRM) company, to enhance its customer support services. This move further signifies Fluent’s dedication to creating seamless digital experiences that empower consumers to engage with the products and services that enrich their lives.Collecting first-party, self-declared data across its proprietary media properties, Fluent helps advertisers deliver relevant offers to the right audiences. By integrating Zendesk, Fluent seeks to enable faster, more efficient processes for tracking, prioritizing, and resolving customer support tickets. Serving more than 150,000 customers across hundreds of industries, Zendesk’s...

Continue reading

Deer Horn Partner Plans to Import COVID-19 Test Kits into Canada

VANCOUVER, British Columbia, June 10, 2020 (GLOBE NEWSWIRE) — Deer Horn Capital Inc. (CSE: DHC) (the “Company” or “Deer Horn”), announces that its Indigenous partner Cheona Health is preparing to import COVID-19 test kits and other related equipment to Canada to help Indigenous peoples and all Canadians manage the COVID-19 pandemic. Initially, management of Cheona Health is launching discussions with the Province of British Columbia to supply accurate, reliable and affordable COVID-19 PCR (polymerase chain reaction) test kits, for which Cheona Health has exclusive access to over 1 million kits, ready for shipment, through an approved South Korean supplier. The kits are Canada Health approved and also cleared to market under the FDA’s Emergency Use Authorization (EUA). Under Provincial and Federal laws, management of Cheona Health...

Continue reading

Catalyst Biosciences Completes MarzAA Pharmacokinetic & Pharmacodynamic Study

SOUTH SAN FRANCISCO, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company developing novel subcutaneous (SQ) therapies for hemophilia and other bleeding disorders, today announced completion of its Phase 1 MAA-102 study for Marzeptacog alfa (activated) (MarzAA). The results support the use of SQ MarzAA to treat episodic bleeding. The company is on track to enroll the first patient in its Phase 3 registration trial evaluating the efficacy of SQ MarzAA to treat bleeding events in individuals with hemophilia A or B with inhibitors in 2020.“Successful completion of our Phase 1 study, in the midst of the global coronavirus pandemic, demonstrates the commitment of our team and is one more step towards enrolling the first patient in our pivotal Phase 3 trial for MarzAA later this...

Continue reading

Jounce Therapeutics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference

CAMBRIDGE, Mass., June 10, 2020 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Jounce management will participate in a fireside chat at the Raymond James Human Health Innovation Conference on Wednesday, June 17, 2020 at 3:00 p.m. ET.A live webcast of the presentation will be available by visiting “Events and Presentations” in the Investors and Media section of Jounce’s website at www.jouncetx.com. A replay of the webcast will be archived for 30 days following the presentation.About Jounce TherapeuticsJounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.